With the proliferation of InsurTech in the life insurance industry, many direct writing companies are struggling to evaluate the abundance of new evidence-based UW tools and how to incorporate them into their underwriting paradigm. Gen Re has embarked on this journey with clients and vendors, and can provide some insights on the use of data science to evaluate the true potential of these new tools.
Attend this session and you’ll:
• Understand the complexities of evaluating new sources of underwriting evidence • Learn how data science can be used to measure their contribution to business value.
Track: Cultivating Future Opportunities